Evolent Health
183 hedge funds and large institutions have $611M invested in Evolent Health in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 84 increasing their positions, 34 reducing their positions, and 39 closing their positions.
Holders
183
Holders Change
-9
Holders Change %
-4.69%
% of All Funds
3.98%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
33
Increased
84
Reduced
34
Closed
39
Calls
$6.01M
Puts
$1.82M
Net Calls
+$4.2M
Net Calls Change
+$2.48M
Top Buyers
| 1 |
CS
1
Credit Suisse
Zurich,
Switzerland
|
$25.9M |
| 2 |
2
Citigroup
New York
|
$9.18M |
| 3 |
BG
3
Bellevue Group
Kuesnacht,
Switzerland
|
$18.7M |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$12.8M |
| 5 |
LOAMU
5
Lombard Odier Asset Management (USA)
New York
|
$7.04M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
226
Daiwa Securities Group
Tokyo,
Japan
| – | – | – | – |
|
|
SCA
227
Stonebridge Capital Advisors
St Paul,
Minnesota
| $0 | 20 | +20 | New |
|